Activity of Docetaxel in Platinum-Treated Non–Small-Cell Lung Cancer: Results of a Phase II Multicenter Trial

Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials

1995 • 2,804 citations

A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung Cancer

1994 • 1,244 citations

An Information-Intensive Approach to the Molecular Pharmacology of Cancer

1997 • 1,177 citations

A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer

1990 • 1,163 citations

A Randomized Trial Comparing Perioperative Chemotherapy and Surgery With Surgery Alone in Resectable Stage IIIA Non-Small-Cell Lung Cancer

1994 • 1,100 citations

Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents.

1997 • 872 citations

Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.

1994 • 836 citations

Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience.

1991 • 732 citations

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary Results of a Phase III Trial in Regionally Advanced, Unresectable Non-Small-Cell Lung Cancer

1995 • 721 citations

Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.

1988 • 704 citations

Taxol induces bcl-2 phosphorylation and death of prostate cancer cells.

1996 • 662 citations

Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study.

1998 • 577 citations

Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer.

1995 • 257 citations

Taxol induction of p21WAF1 and p53 requires c-raf-1.

1995 • 187 citations

Paclitaxel by 1-hour infusion: an active drug in metastatic non-small-cell lung cancer.

1995 • 161 citations

Failure of vinorelbine to produce responses in pretreated non-small cell lung cancer patients.

1994 • 56 citations

Promising new agents in the treatment of non-small cell lung cancer

1996 • 49 citations

Gemcitabine as second-line treatment for relapsing or refractory advanced non-small cell lung cancer: a phase II trial.

1998 • 22 citations

[Early phase II clinical study of KW-2307 in patients with lung cancer. Lung Cancer Section in KW-2307 Study Group].

1994 • 8 citations

p27/Kip1 induction is a potential p53-independent mechanism of apoptotic response to docetaxel in non-small cell lung carcinoma (NSCLC) cell lines

2000 • 3 citations